KEAP1 and type 2 diabetes mellitus: Wang et al. reported that NaHS treatment in db/db mice with type 2 diabetes (T2D) increased Keap1 ubiquitination by preserving its E3 ligase synoviolin (Syvn1), resulting in the nuclear translocation of Nrf2.